This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Conrad, K. P. Articles by Shroff, S. G. Search for Related Content PubMed PubMed Citation Articles by Conrad, K. P. Articles by Shroff, S. G.

Relaxin Modifies Systemic Arterial Resistance and Compliance in Conscious, Nonpregnant Rats

Departments of Obstetrics, Gynecology and Reproductive Sciences and Cell Biology and Physiology (K.P.C., J.N.), University of Pittsburgh School of Medicine and Magee-Womens Research Institute, and Department of Bioengineering (D.O.D., S.G.S.), University of Pittsburgh, Pittsburgh, Pennsylvania 15213; and Department of Pathology (L.A.D.), University of New Mexico School of Medicine, Albuquerque, New Mexico 87131

Address all correspondence and requests for reprints to: Kirk P. Conrad, M.D., Magee-Womens Research Institute, 204 Craft Avenue, Pittsburgh, Pennsylvania 15213. E-mail: rsikpc{at}mwri.magee.edu.

Relaxin emanates from the corpus luteum of the ovary and circulates during pregnancy. Because the hormone is a potent renal vasodilator and mediates the renal vasodilation and hyperfiltration of pregnancy in conscious rats, we reasoned that it might also contribute to the broader cardiovascular changes of pregnancy. We began investigating this concept by testing whether relaxin can modify systemic arterial hemodynamics and load when chronically administered to nonpregnant rats. The major objectives of the present work were to determine whether relaxin administration to nonpregnant rats 1) modifies cardiac output (CO), systemic vascular resistance, and global arterial compliance (AC), and 2) regulates the passive mechanics of isolated arteries. To accomplish the first objective, we developed a conscious rat model for assessment of global AC. Passive mechanics of small renal arteries were assessed using a pressure arteriograph. Chronic administration of recombinant human relaxin by sc osmotic minipump to conscious, female, nonpregnant rats reduced the steady arterial load by decreasing systemic vascular resistance, increased CO, and reduced the pulsatile arterial load by increasing global AC as quantified by two indices—AC estimated from the diastolic decay of aortic pressure and CO and AC estimated by the ratio of stroke volume-to-pulse pressure. In another group of rats, relaxin administration also regulated the passive mechanics of small renal arteries, indicating that, in addition to reduction in vascular smooth muscle tone, modification of the vascular structure (e.g. extracellular matrix) contributes to the increase in global AC. These findings suggest a role for relaxin in the systemic hemodynamic changes of pregnancy, as well as novel therapeutic potential for relaxin in modifying arterial stiffness and cardiac afterload.

This article has been cited by other articles:

				E. E. Shaw, P. Wood, J. Kulpa, F. H. Yang, A. J. Summerlee, and W. G. Pyle Relaxin alters cardiac myofilament function through a PKC-dependent pathway Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H29 - H36. [Abstract] [Full Text] [PDF]

				J. Novak, L. J. Parry, J. E. Matthews, L. J. Kerchner, K. Indovina, K. Hanley-Yanez, K. D. Doty, D. O. Debrah, S. G. Shroff, and K. P. Conrad Evidence for local relaxin ligand-receptor expression and function in arteries FASEB J, November 1, 2006; 20(13): 2352 - 2362. [Abstract] [Full Text] [PDF]

				D. O. Debrah, J. Novak, J. E. Matthews, R. J. Ramirez, S. G. Shroff, and K. P. Conrad Relaxin Is Essential for Systemic Vasodilation and Increased Global Arterial Compliance during Early Pregnancy in Conscious Rats Endocrinology, November 1, 2006; 147(11): 5126 - 5131. [Abstract] [Full Text] [PDF]

				M. C. Smith, Lee. A. Danielson, Kirk. P. Conrad, and J. M. Davison Influence of Recombinant Human Relaxin on Renal Hemodynamics in Healthy Volunteers J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3192 - 3197. [Abstract] [Full Text] [PDF]

				D. O. Debrah, K. P. Conrad, A. Jeyabalan, L. A. Danielson, and S. G. Shroff Relaxin Increases Cardiac Output and Reduces Systemic Arterial Load in Hypertensive Rats Hypertension, October 1, 2005; 46(4): 745 - 750. [Abstract] [Full Text] [PDF]

				D. O. Debrah, K. P. Conrad, L. A. Danielson, and S. G. Shroff Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response J Appl Physiol, March 1, 2005; 98(3): 1013 - 1020. [Abstract] [Full Text] [PDF]

				K. P. Conrad and J. Novak Emerging role of relaxin in renal and cardiovascular function Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261. [Abstract] [Full Text] [PDF]